Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy
- 28 April 2009
- journal article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 135 (10), 1429-1435
- https://doi.org/10.1007/s00432-009-0587-3
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cellsBlood, 2008
- Captopril as a Potential Inhibitor of Lung Tumor Growth and MetastasisAnnals of the New York Academy of Sciences, 2008
- Anti-cancer actions of a recombinant antibody (R6313/G2) against the angiotensin II AT1 receptorEndocrine-Related Cancer, 2008
- Pharmacology and new perspectives of angiotensin II receptor blocker in prostate cancer treatmentInternational Journal of Urology, 2008
- Renin–angiotensin–aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?Acta Diabetologica, 2005
- Hypertension mega-trials with cardiovascular end points: Effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockersAmerican Heart Journal, 2004
- Effects of the angiotensin-I converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cellsZeitschrift für Krebsforschung und Klinische Onkologie, 2004
- Direct evidence of leukocyte adhesion in arterioles by angiotensin IIBlood, 2004
- Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cellsJournal of Cellular Physiology, 2003
- Differences between Squamous Cell Carcinoma and Keratoacanthoma in Angiotensin Type-1 Receptor ExpressionThe American Journal of Pathology, 2001